论文部分内容阅读
目的探讨氨溴索、可必特联合雾化吸入治疗AECOPD的疗效。方法将480例AECO-PD患者随机分为治疗组和对照组两组。治疗组240例,对照组240例,对照组给予吸氧、抗感染、静脉滴注氨茶碱、甲基强的松龙、祛痰,对症及支持治疗;治疗组在上述治疗基础上加用氨溴索、可必特联合雾化吸入治疗。对治疗前后的症状、体征和指脉氧血氧饱和度等指标进行比较分析。结果治疗组有效率明显高于对照组,治疗前后指脉氧血氧饱和度比较,治疗组有统计学意义(P<0.05)。结论氨溴索、可必特联合雾化吸入治疗AECOPD效果满意,值得临床推广使用。
Objective To investigate the efficacy of ambroxol and bilirubin combined with inhalation in the treatment of AECOPD. Methods 480 patients with AECO-PD were randomly divided into treatment group and control group. The treatment group 240 cases, control group 240 cases, the control group were given oxygen, anti-infection, intravenous aminophylline, methylprednisolone, expectorant, symptomatic and supportive treatment; treatment group based on the above treatment Ambroxol may be combined with inhalation therapy. Before and after treatment of symptoms and signs and finger oxygen saturation index were compared. Results The effective rate of the treatment group was significantly higher than that of the control group. The oxygen saturation of the finger before and after the treatment was statistically significant (P <0.05). Conclusions Ambroxol can be combined with aerosol inhalation in the treatment of AECOPD with satisfactory results, which is worthy of clinical application.